| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |